Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Fluorine-18 PBR 06 (Primary) ; Verdiperstat (Primary)
- Indications Multiple system atrophy
- Focus Diagnostic use; Pharmacodynamics
- 18 Aug 2022 Status changed from active, no longer recruiting to completed.
- 21 Oct 2021 Planned number of patients changed from 8 to 25.
- 22 Sep 2021 Study design presented at the 25th International Congress of Parkinson's Disease and Movement Disorders